Nutex Health, INC 10-Q quarterly reports

Nutex Health Inc. reported a significant turnaround in Q3 2025, achieving substantial net income and revenue growth driven by its hospital division and successful independent dispute resolution outcomes.

Nutex Health posted a 221% jump in total revenue to $244M and strong operating income in Q2 2025, but recorded a $17.7M loss attributable to common shareholders amid large stock-based charges and high noncontrolling interests.

Nutex Health amended Q1 2025 results to reclassify stock-based obligations as liabilities, lifting EPS and net income while reaffirming a material weakness in internal controls.

Nutex Health Inc. announces a significant increase in net income and revenue for the first quarter of 2025, driven by higher patient visits and successful arbitration efforts.

Nutex Health Inc. saw a significant increase in revenue and adjusted EBITDA in the third quarter of 2024, driven by higher patient visits and improved reimbursement rates, though the company still reported a net loss.

Nutex Health saw a significant improvement in its second quarter results, driven by increased patient visits and higher revenue per visit, despite ongoing challenges with the No Surprises Act.

Nutex Health Inc. saw a significant reduction in net loss and an increase in revenue for the first quarter of 2024, driven by higher patient visits and improved collections.